— Know what they know.
Not Investment Advice
Also trades as: OVAT.CN (CNQ) · $vol 0M

OVATF OTC

Ovation Science Inc.
1W: +0.0% 1M: +0.0% 3M: -78.6% YTD: -74.6% 1Y: -70.9% 3Y: -58.6% 5Y: -96.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · $288313 mcap · 29M float · 0.034% daily turnover · Short 57% of daily vol

Income Trends

Revenue
$113K +82.8% ▲
5Y CAGR: -17.8%
Gross Profit
$86K +58.4% ▲
5Y CAGR: -21.3%
Operating Income
-$479K +31.1% ▲
Net Income
-$456K +43.9% ▲
EPS (Diluted)
$-0.01 +51.5% ▲
EBITDA
-$404K +48.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$750K$225K$138K$62K$113K
YoY Growth+148.0%-70.0%-38.6%-55.2%+82.8%
Cost of Revenue$202K$37K$3K$8K$27K
Gross Profit$548K$188K$135K$54K$86K
Gross Margin73.1%83.6%97.8%87.4%75.7%
R&D Expenses$130K$83K$65K$9K$13K
SG&A Expenses$1M$926K$448K$473K$254K
Operating Expenses$2M$1M$928K$749K$565K
Operating Income-$935K-$2M-$739K-$695K-$479K
Operating Margin-124.6%-674.1%-534.7%-1122.4%-423.1%
Interest Expense$16K$0$588$31K$50K
Income Before Tax-$1M-$2M-$794K-$813K-$456K
Tax Expense$0$0$0$0$0
Net Income-$1M-$2M-$794K-$813K-$456K
Net Margin-158.0%-1064.1%-574.8%-1312.9%-402.9%
EPS (Diluted)$-0.04$-0.08$-0.03$-0.03$-0.01
EBITDA-$1M-$2M-$787K-$779K-$404K
Shares Outstanding27M29M29M30M35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms